Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ju-Yeon Cho, Won Sohn

Clin Mol Hepatol. 2023;29(2):374-376. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0084

View: 3555 Download: 73 Web of Science: 6 Crossref: 7

Peter Konyn, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2023;29(2):358-362. Published online March 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0092

View: 4176 Download: 76 Web of Science: 9 Crossref: 9

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0070

View: 6682 Download: 139 Web of Science: 51 Crossref: 56

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Seung Ha Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(4):652-661. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0160

View: 7297 Download: 138 Web of Science: 34 Crossref: 40

1 |

Viewed By 7184	MAFLD: How is it different from NAFLD?
Viewed By 6633	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5468	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5257	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4734	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 269	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 181	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search